Related Experiment Video
Updated: Jun 16, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Precision geospatial targeting for cost-effective tuberculosis case finding in Eastern Uganda: a quasi-experimental
Clark Joshua Brianwong1, Diana Cherotin2, Lwanga Sssekiswa Zimwanguyiza2
1Medical and psychosocial, Baylor College of Medicine Children's Foundation Uganda, Kampala 72052, Uganda.
Background:
Universal community-based tuberculosis (TB) screening in high-burden settings is resource-intensive and inefficient, frequently missing cases and leading to suboptimal resource allocation. Integrating routine surveillance data with geospatial analytics offers a promising approach to enhance the efficiency and cost-effectiveness of active case finding.
Objective:
To evaluate whether integrating Uganda's electronic Case-Based Surveillance System (eCBSS) data with geospatial hotspot analytics improves the efficiency, yield and cost-effectiveness of integrated TB case finding (CAST+) in Eastern Uganda.
Design:
We conducted a quasi-experimental before-and-after study comparing a universal community screening campaign (September 2022) with a geospatially targeted campaign (March 2024) in Eastern Uganda.
Methods:
We analysed routine eCBSS data from 166 diagnostic and treatment units using a sequential two-stage geospatial approach in Quantum Geographic Information System (QGIS). Statistically significant hotspot parishes were identified using the Getis-Ord Gi* statistic (p < 0.05), followed by the prioritisation of villages reporting > 2 bacteriologically confirmed TB cases (March 2023-February 2024). Comparative effectiveness was assessed with a cluster-adjusted chi-square test (Rao-Scott correction). Cost-effectiveness was evaluated from the provider perspective using inflation-adjusted 2024 USD costs, disability-adjusted life years (DALYs) averted, cost-effectiveness ratios (CERs) and incremental cost-effectiveness ratios (ICERs).
Results:
The targeted strategy screened 49,373 individuals across 313 villages, compared with 627,082 in 3252 villages under the universal campaign, representing a 92.1% reduction in screening volume. Despite this, TB yield increased by 10% (1.68%-1.85%; p < 0.001). Total inflation-adjusted costs declined by 90.9% (from USD 62,804 to USD 5704), unit cost per TB case fell by 55.2% (USD 82.20-USD 36.80), and cost per DALY averted decreased from USD 4.72 to USD 2.11 (ICER: USD 5.39 per DALY averted). All diagnosed TB cases were initiated on treatment.
Conclusion:
eCBSS-guided geospatial targeting improved efficiency, precision and cost-effectiveness of TB screening, supporting a shift from universal to targeted TB case finding, and provides programmatic evidence for high-value public health interventions in resource-limited settings.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

